Business Description
Danapha Pharmaceutical JSC
ISIN : VN000000DAN1
Description
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 70.16 | |||||
| 9-Day RSI | 59.12 | |||||
| 14-Day RSI | 54.88 | |||||
| 6-1 Month Momentum % | -14.87 | |||||
| 12-1 Month Momentum % | 4.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.3 | |||||
| Forward Dividend Yield % | 2.3 | |||||
| 5-Year Yield-on-Cost % | 2.37 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Danapha Pharmaceutical JSC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚«) | |||
| EPS (TTM) (â‚«) | 0 | ||
| Beta | 0 | ||
| Volatility % | 32.58 | ||
| 14-Day RSI | 54.88 | ||
| 14-Day ATR (â‚«) | 663.827846 | ||
| 20-Day SMA (â‚«) | 29555 | ||
| 12-1 Month Momentum % | 4.29 | ||
| 52-Week Range (â‚«) | 24400 - 36400 | ||
| Shares Outstanding (Mil) | 20.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Danapha Pharmaceutical JSC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Danapha Pharmaceutical JSC Stock Events
| Event | Date | Price(â‚«) | ||
|---|---|---|---|---|
| No Event Data | ||||
Danapha Pharmaceutical JSC Frequently Asked Questions
What is Danapha Pharmaceutical JSC(HSTC:DAN)'s stock price today?
The current price of HSTC:DAN is â‚«30500.00. The 52 week high of HSTC:DAN is â‚«36400.00 and 52 week low is â‚«24400.00.
When is next earnings date of Danapha Pharmaceutical JSC(HSTC:DAN)?
The next earnings date of Danapha Pharmaceutical JSC(HSTC:DAN) is .
Does Danapha Pharmaceutical JSC(HSTC:DAN) pay dividends? If so, how much?
The Dividend Yield %  of Danapha Pharmaceutical JSC(HSTC:DAN) is 2.3% (As of Today), Highest Dividend Payout Ratio of Danapha Pharmaceutical JSC(HSTC:DAN) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Danapha Pharmaceutical JSC(HSTC:DAN) is 2.3%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers